The Marcus (MCS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
9 Jul, 2026Executive summary
Fiscal Q1 2025 revenues rose 7.4% year-over-year to $148.8 million, aided by four extra operating days from a fiscal calendar change, with both theatre and hotel segments contributing.
Operating loss widened to $20.4 million, impacted by higher labor, film costs, depreciation, and stock-based compensation, partially offset by a property gain.
Net loss increased to $16.8 million from $11.9 million year-over-year, with diluted EPS at $(0.54) versus $(0.38) prior year.
Adjusted EBITDA was a loss of $0.3 million, down from $2.3 million in Q1 2024, mainly due to higher costs in theatres and corporate.
Over $25 million was returned to shareholders in the past four quarters, including $7.1 million in Q1 share repurchases.
Financial highlights
Consolidated revenue increased by $10.2 million year-over-year, with $9.2 million attributed to the calendar change.
Total costs and expenses rose to $169.2 million from $155.2 million, driven by higher labor, film costs, and depreciation.
Cash flow from operations was a use of $35.3 million, impacted by working capital seasonality and lower EBITDA.
Capital expenditures were $23 million, mainly for Hilton Milwaukee renovations and theatre maintenance.
Net cash and equivalents at quarter-end were $11.9 million.
Outlook and guidance
Full-year outlook remains positive, with expectations for growth in both theaters and hotels, supported by a strong summer movie slate and hotel renovations.
Capital expenditures for fiscal 2025 are projected at $70–$85 million.
Fiscal 2025 effective tax rate expected in the 28–32% range, barring one-time items or tax law changes.
Group room revenue bookings for hotels are over 11% ahead for 2025 and over 20% ahead for 2026 versus prior year pace.
Leisure travel demand expected to soften near-term, with group business remaining stable.
Latest events from The Marcus
- Q2 revenue fell 15% as hotels outperformed and theaters rebounded with improved film supply.MCS
Q2 20248 Jul 2026 - Board, compensation, and auditor votes passed overwhelmingly; no Q&A from shareholders.MCS
AGM 202621 May 2026 - Revenue up 3.8% and losses narrowed as both divisions outperformed industry benchmarks.MCS
Q1 202630 Apr 2026 - Both divisions outperformed peers in 2025, with strong revenue growth and a robust 2026 outlook.MCS
Q4 20258 Apr 2026 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG and governance.MCS
Proxy filing7 Apr 2026 - Virtual annual meeting to vote on directors, pay, and auditor ratification, all board-backed.MCS
Proxy filing7 Apr 2026 - 2025 revenue reached $758.5M with strong theatre and hotel performance and robust growth outlook.MCS
Investor presentation5 Mar 2026 - Record Q3 revenue, earnings, and industry outperformance with a strengthened capital structure.MCS
Q3 202417 Jan 2026 - Q4 revenue up 16.6% and record hotel results, with strong momentum for 2025 growth.MCS
Q4 202423 Dec 2025